Surgery Partners, Inc.
SGRY
$17.07
$0.010.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.29B | 3.24B | 3.17B | 3.11B | 2.99B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.29B | 3.24B | 3.17B | 3.11B | 2.99B |
| Cost of Revenue | 2.50B | 2.47B | 2.42B | 2.37B | 2.28B |
| Gross Profit | 786.40M | 768.60M | 752.20M | 745.60M | 705.60M |
| SG&A Expenses | 130.50M | 137.30M | 141.50M | 138.70M | 123.60M |
| Depreciation & Amortization | 150.00M | 160.70M | 155.20M | 152.60M | 149.80M |
| Other Operating Expenses | -13.10M | -13.60M | -18.00M | -20.00M | -15.00M |
| Total Operating Expenses | 2.77B | 2.75B | 2.70B | 2.64B | 2.54B |
| Operating Income | 519.00M | 484.20M | 473.50M | 474.30M | 447.20M |
| Income Before Tax | 148.50M | 128.60M | 118.10M | 147.10M | 125.60M |
| Income Tax Expenses | 125.20M | 124.20M | 130.20M | 134.60M | 19.80M |
| Earnings from Continuing Operations | 23.30 | 4.40 | -12.10 | 12.50 | 105.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -194.70M | -184.80M | -181.30M | -180.60M | -166.40M |
| Net Income | -171.40M | -180.40M | -193.40M | -168.10M | -60.60M |
| EBIT | 519.00M | 484.20M | 473.50M | 474.30M | 447.20M |
| EBITDA | 669.00M | 644.90M | 628.70M | 626.90M | 597.00M |
| EPS Basic | -1.36 | -1.43 | -1.53 | -1.33 | -0.48 |
| Normalized Basic EPS | -0.13 | -0.10 | -0.05 | 0.02 | 0.00 |
| EPS Diluted | -1.36 | -1.43 | -1.53 | -1.33 | -0.48 |
| Normalized Diluted EPS | -0.13 | -0.10 | -0.05 | 0.02 | 0.00 |
| Average Basic Shares Outstanding | 507.00M | 505.96M | 505.12M | 504.49M | 504.05M |
| Average Diluted Shares Outstanding | 507.00M | 505.96M | 505.12M | 504.49M | 504.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |